In what makes Abbott Laboratories a serious competitor is the much lower price one has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's Guardian.

Second, Dexcom's latest, the G7, can be manufactured at significantly lower-cost, which offers flexibility ... and faster warm-up time than G6. Medicare's decision to reimburse for the G6 and ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...

As Costco reaches a point of maturity in its US and Canadian markets, the firm’s cost leverage may show signs of deterioration.

Here are the stocks making the biggest market moves midday.

Its innovative devices like the G6 and ... pricing and cost pressures possibly driven by competition, as well as innovations in related medical fields. Despite these challenges, DexCom maintained ...

Artisan Mid Cap Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that engages in the ...

Among its flagship products are the Dexcom G6 and G7 integrated CGM systems, which play an important role in helping individuals monitor their glucose levels effectively. As a prominent player in ...

Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous ...